New cancer drugs routinely cost more than $100,000 per patient, even when they bring only modest benefits. And some generic medications are going up in price rapidly. There is a sector of the healthcare industry that has flow under the radar but is just as egregious as more publicized groups.
The Greediest Companies In American Healthcare Are Not Who You Think
